Displaying 1 - 5 of 5
  • Print
Contract Number Brand Code Brand Name Active Ingredient Trade Name Package Size Formulary Category Pkg Price Unit Price Unit Description Max. Reimbursable Quantity / Month Package Description Manufacturer Code Manufacturer Name Agent Code Agent Name Benefit Therapeutic Code Therapeutic Desc Drug Contract Start Date Drug Contract End Date Status Description Default Route Max Repeats Therapeutic Head Amend Date
41 05814 CYTARABINE 100MG INJ (ZUV) (BQ) CYTARABINE CYTARABINE 100MG VIAL BQ 7.48 7.4754 VIAL 100 VIAL ZUV ZUVIUS PHA PHARMACY SALES CARIBBEAN 1000 ANTINEOPLASTICS 2024-04-01 2026-03-31 INJ 6 ANTINEOPLASTICS
41 0581D CYTARABINE 100MG INJ (KWA) (BQ) CYTARABINE CYTARABINE 100MG VIAL BQ 5.55 5.5454 VIAL 100 VIAL KWA KWALITY PHARMACEUTICALS ATB ANSA TRADING BARBADOS LTD 1000 ANTINEOPLASTICS 2024-04-01 2026-03-31 IV 6 ANTINEOPLASTICS
40 0582B CYTARABINE 1G INJ (INP/AHI) CYTARABINE CYTARABINE 1G VIAL BQ 38.46 38.46 INJECTION 0 VIAL INP INTAS PHARMACEUTICALS LTD AHI ARMSTRONG HEALTHCARE INC 1000 ANTINEOPLASTICS 2022-04-01 2024-03-31 IV 0 ANTINEOPLASTICS
40 0582D ONCOTAR 1G INJ (UBI/RXP) CYTARABINE CYTARABINE ONCOTAR 1G VIAL BQ 31.26 31.26 INJECTION 0 VIAL UBI UNITED BIOTECH (P) LIMITED RXP RX PRO INC 1000 ANTINEOPLASTICS 2022-04-01 2024-03-31 IV 0 ANTINEOPLASTICS
41 0582E CYTRAZ 1G INJ (ZUV) CYTARABINE (BQ) CYTARABINE CYTRAZ 1G VIAL BQ 20.69 20.6864 VIAL 0 VIAL ZUV ZUVIUS PHA PHARMACY SALES CARIBBEAN 1000 ANTINEOPLASTICS 2024-04-01 2026-03-31 IV 0 ANTINEOPLASTICS